Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

  • TORCMEK

    A Phase Ib/IIa study of AZD2014 in combination with Selumetinib in patients with advanced cancers

    View Trial
  • A prospective observational study examining the role of myocardial fibrosis in outcome following mitral valve repair in degenerative mitral regurgitation

    View Trial
  • LIFT

    Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation

    View Trial
  • Native T1 Mapping by Cardiovascular Resonance Imaging in Rare Diseases – A new method to improve patient care

    View Trial
  • BiCARB

    Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis?

    View Trial
  • M14-483 ABT-414

    ABT-414 alone or ABT-414 plus temozolomide versus lomustine or temozolomide for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group

    View Trial
  • How do Health Care Professionals care for patients with dementia in an acute hospital setting?

    View Trial
  • A multi centre double blind double dummy randomised positive controlled study comparing the efficacy and safety of Lacosamide (200 to 600mg/day) to controlled release Carbamazepine (400 to 1200mg/day) used as Monotherapy in subjects (=16 years) newly or recently diagnosed with Epilepsy and experiencing partial onset or generalised Tonic Clonic Seizures

    View Trial
  • Cogwatch

    Cognitive Rehabilitation of Apraxia and Action Disorganisation Syndrome

    View Trial
  • The ACQUATIK Study

    Acute Care QUAliTy in chronic Kidney Disease

    View Trial